Daily Health Headlines

Alcohol May Fuel Prostate Cancer Risk

👤by Robert Preidt 0 comments 🕔Wednesday, November 16th, 2016

TUESDAY, Nov. 15, 2016 (HealthDay News) -- Drinking may raise the risk of prostate cancer, and the more men drink the greater their risk, a new analysis of 27 studies suggests.

Canadian and Australian scientists found a significant association between alcohol and prostate cancer risk, though they did not prove that drinking caused prostate cancer risk to rise.

Even low levels of drinking (up to two drinks a day) were associated with an 8 to 23 percent higher risk of prostate cancer when compared to no drinking, the researchers said.

"This new study contributes to the strengthening evidence that alcohol consumption is a risk factor for prostate cancer. Alcohol's contribution to prostate cancer will need to be factored into future estimates of the global burden of disease," said study co-author Tim Stockwell in a University of Victoria news release. He is director of the university's Centre for Addictions Research of BC in Canada.

Study co-author Tanya Chikritzhs leads the Alcohol Policy Research Team at Australia's National Drug Research Institute. "These findings highlight the need for better methods in research on alcohol and health," she said. "Past and future studies that demonstrate protection from disease due to low-level drinking should be treated with caution."

Prostate cancer is the fifth leading cause of cancer death in men worldwide.

Alcohol is a known risk factor for breast cancer and at least seven types of digestive system cancers, and alcohol may also increase the risk of cancers of the skin and pancreas, the researchers said.

The study was published online Nov. 15 in the journal BMC Cancer.

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: University of Victoria, news release

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!